Detalles de la búsqueda
1.
Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARL.
Ann Oncol
; 32(4): 488-499, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33385521
2.
Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial.
Ann Oncol
; 30(10): 1613-1621, 2019 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31504118
3.
Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trial.
Ann Oncol
; 26(1): 132-140, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25319061
4.
Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2.
Ann Oncol
; 25(4): 808-815, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24615500
5.
Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN).
Invest New Drugs
; 32(6): 1278-84, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24894651
6.
A phase II study of retifanlimab, a humanized anti-PD-1 monoclonal antibody, in patients with solid tumors (POD1UM-203).
ESMO Open
; 9(3): 102387, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38401247
7.
Population Pharmacokinetics of Liposomal Irinotecan in Patients With Cancer.
Clin Pharmacol Ther
; 102(6): 997-1005, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28445610
Resultados
1 -
7
de 7
1
Próxima >
>>